المؤلفون: Chen, Zhiao^{Aff1, Aff2, Aff3}, Shi, Qili, Zhao, Yiming, Xu, Midie, Liu, Yizhe, Li, Xinrong, Liu, Li, Sun, Menghong, Wu, Xiaohua, Shao, Zhimin^{Aff2, Aff7}, Xu, Ye^{Aff8, IDs4036402300554w_cor11}, Wang, Lu^{Aff4, IDs4036402300554w_cor12}, He, Xianghuo^{Aff1, Aff2, Aff3, IDs4036402300554w_cor13}

المصدر: Biomarker Research. 12(1)

المؤلفون: Wu, Yangjun, Wang, Jiajia, Zhao, Jingjing, Su, Yue, Li, Xinrong, Chen, Zhiao, Wu, Xiaohua, Huang, Shenglin, He, Xianghuo, Liang, Linhui

المصدر: In Cancer Letters 28 August 2024 598

المؤلفون: Liu, Yizhe, Shi, Qili, Liu, Yanfang, Li, Xinrong, Wang, Zhen, Huang, Shenglin, Chen, Zhiao, He, Xianghuo

المصدر: In Cancer Letters 10 October 2024 602

المؤلفون: Shi, Qili, Liu, Teng^{Aff2, Aff3}, Hu, Wei, Chen, Zhiao, He, Xianghuo^{Aff1, IDs40364022003771_cor5}, Li, Shengli^{Aff2, IDs40364022003771_cor6}

المصدر: Biomarker Research. 10(1)

المؤلفون: Chen Zhiao, He Xianghuo

المصدر: Medical Review, Vol 1, Iss 2, Pp 150-171 (2021)

مصطلحات موضوعية: alternative splicing, application, cancer genome, epigenome, third-generation sequencing, Medicine

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2749-9642

URL الوصول: https://doaj.org/article/efd1600dbcdb42ac8e19e84e56e679b0

المؤلفون: Shen, Mengting, Li, Shengli, Zhao, Yiming, Liu, Yizhe, Liu, Zhen, Huan, Lin, Qiao, Yejun, Wang, Lu^{Aff3, IDs41419022051879_cor8}, Han, Leng^{Aff4, IDs41419022051879_cor9}, Chen, Zhiao^{Aff1, Aff5, Aff6, IDs41419022051879_cor10}, He, Xianghuo^{Aff1, Aff5, Aff6, IDs41419022051879_cor11}

المصدر: Cell Death & Disease. 13(8)

المؤلفون: Chen, Zhiao, Li, Shengli, Shen, Mengting, Lu, Xinyuan, Bao, Chunyang, Chen, Di, Ding, Jie, Wang, Qifeng, Huang, Shenglin, Cong, Wenming, Han, Leng, He, Xianghuo

المصدر: In iScience 20 November 2020 23(11)

المؤلفون: Shi, Qili, Li, Xinrong, Liu, Yizhe, Chen, Zhiao, He, Xianghuo

المصدر: Nucleic Acids Research; 1/5/2024, Vol. 52 Issue D1, pD124-D133, 10p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.